Granata Bio is a biopharma company focused on women's health and infertility. Our mission and focus is to create access for fertility patients by introducing new therapeutic solutions.
Location: United States, Massachusetts, Duxbury
Total raised: $29M
Founded date: 2018
Investors 1
| Date | Name | Website |
| 28.08.2024 | What If Ve... | whatif.vc |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 26.01.2025 | Series A | $15M | - |
| 28.01.2024 | Series A | $14M | - |
Mentions in press and media 8
| Date | Title | Description |
| 15.05.2025 | Granata Bio Receives Investment From Gedeon Richter | Granata Bio, a Boston, MA-based biotechnology company focused on advancing fertility therapeutics, received an investment from Gedeon Richter. The amount of the deal was not disclosed. The company intends to use the funds to expand operatio... |
| 26.01.2025 | Granata Bio: $15 Million (Series A+) Raised To Expand Reproductive Health Pipeline | Granata Bio – a biopharma company focused on invigorating the global infertility medication market – announced its $15 million Series A+ funding round. The funding round was exclusively supported by existing investors, including Gedeon Rich... |
| 15.01.2025 | Granata Bio Raises $15M in Series A+ Funding | Granata Bio Corporation, a Boston, MA-based biopharma company, raised $15M in Series A+ funding. The round saw participation from Gedeon Richter, CooperSurgical, Amboy Street Ventures, and other strategic investors. The company intends to u... |
| 03.04.2024 | Fertility benefits help your company stand out among competitors | Chanel, Google, Walmart & Starbucks are the frontrunners of this employee benefits trend A well-rounded benefits package plays a significant role in hiring and retaining the best talent – not to mention reinforcing company values and bo... |
| 13.03.2024 | IVF uncertainty aside, startups rush to offer fertility care amid rising demand | AI tools, egg freezing, surrogacy, IUI, donorship, oncofertility, genetic analysis, loans, and more In the aftermath of the Roe v. Wade overturn, U.S. fertility clinics (and patients alongside them) are battling an unlikely complication in ... |
| 28.01.2024 | Granata Bio Closes $14M Series A Funding | BOSTON, MA, Granata Bio, a biopharma company, announced the close of a $14M Series A funding round led by GV. >> Click here for more funding data on Granata Bio >> To export Granata Bio funding data to PDF and Excel, click h... |
| 16.01.2024 | Granata Bio Raises $14M in Series A Funding | Granata Bio, a Boston, MA-based biopharma company focused on the infertility medication market, raised $14M in Series A funding. The round was led by GV (Google Ventures) with participation from CooperSurgical, Gedeon Richter, Alumni Ventur... |
| - | Granata Bio | “Granata Bio is a biopharma company focused on women's health and infertility. Our mission and focus is to create access for fertility patients by introducing new therapeutic solutions.” |